Actemra™ (tocilizumab)– Emergency use authorization approval
June 24, 2021 - The FDA announced the emergency use authorization (EUA) approval of Genentech’s Actemra (tocilizumab), for the treatment of COVID-19 in hospitalized adults and pediatric patients (2 years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.
Top